Remove Compounding Remove Documentation Remove HIPAA
article thumbnail

Satisfy Online Ad Requirements with NABP’s Healthcare Merchant Accreditation

National Association of Boards of Pharmacy

For example, Form 483 Notifications or Warning Letters that you or your affiliates have received from the Food and Drug Administration (FDA) relating to pharmacy compounding must be resolved. These include all licenses, previous disciplinary actions, and other supporting documents. Model notices are posted on HHS’ website.

HIPAA 45